Details for 2013770771
Up to date per 02.04.2026
Actions
Details for 2013770771
Granted/Registered
European Patent
29.07.2015 A
06.06.2018 B1
20.09.2012
US
201261703533 P
01.10.2012
US
201261708070 P
A61K 45/06 20060101AFI20140410BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
Representative
Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT
Inventor
GOLDBRUNNER, Michaelc/o Novartis Pharma AG Postfach 4002 BaselCH
HUANG, Xizhongc/o Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge Massachusetts 02139US
Information about Fees